A. Bossios (Stockholm, Sweden), V. Backer (Copenhagen, Denmark)
Frequencies of Regulatory CD8TIGIT T Cells Reflect Disease Status in COPD
J. Hou (Yinchuan, China), H. Li (Yinchuan, China), Z. Tian (Yinchuan, China), X. Zheng (Yinchuan, China)
|   |
Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations
A. Chakrabarti (South San Francisco, United States of America), D. Choy (South San Francisco, United States of America), X. Yang (South San Francisco, United States of America), Y. Cao (South San Francisco, United States of America), W. Tew (South San Francisco, United States of America), J. Mar (South San Francisco, United States of America), N. Rathore (South San Francisco, United States of America), O. Li (South San Francisco, United States of America), M. Grimbaldeston (South San Francisco, United States of America), C. Brightling (Leicester, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Rosenberger (South San Francisco, United States of America)
| |
Characterisation of patients hospitalised for asthma exacerbations in Hong Kong
K. Chan (Hong Kong, Hong Kong), F. Ko (Hong Kong, Hong Kong), K. Ling (Hong Kong, Hong Kong), L. Chan (Hong Kong, Hong Kong), Y. Chan (Hong Kong, Hong Kong), Y. Lo (Hong Kong, Hong Kong), C. Ng (Hong Kong, Hong Kong), M. Lui (Hong Kong, Hong Kong), K. Yee (Hong Kong, Hong Kong), C. Tseng (Hong Kong, Hong Kong), P. Tse (Hong Kong, Hong Kong), M. Wong (Hong Kong, Hong Kong), K. Choo (Hong Kong, Hong Kong), W. Lam (Hong Kong, Hong Kong), C. Wong (Hong Kong, Hong Kong), S. Ho (Hong Kong, Hong Kong), C. Lun (Hong Kong, Hong Kong), C. Lai (Hong Kong, Hong Kong)
| |
Associations between eosinophil mediators and asthma characteristics in adults: the EGEA study
v. Granger (Paris, France), F. Zerimech (Lille, France), J. Arab (Mont Liban, Lebanon), V. Siroux (Grenoble, France), P. De-Nadai (Lille, France), A. Tsicopoulos (lille, France), R. Matran (Lille, France), Z. Akiki (Beirut, Lebanon), R. Nadif (Villejuif, France)
| |
Obese asthmatics with impaired FRC show increased eosinophilic inflammation
A. James (Stockholm, Sweden), L. Andersson (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), A. Bossios (Stockholm, Sweden), .. On Behalf Of Bioair Study Group (Stockholm, Sweden)
| |
The German Severe Asthma Registry: Obesity is associated with asthma parameters
C. Bal (Vienna, Austria), S. Škrgat (Golnik, Slovenia), A. Koch (Davos, Switzerland), K. Milger (Munich, Germany), C. Schulz (Regensburg, Germany), E. Hamelmann (Bielefeld, Germany), R. Buhl (Mainz, Germany), S. Korn (Mainz, Germany), M. Idzko (Vienna, Austria)
| |
Neutrophilic asthma: a distinct phenotype?
T. Kole (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), W. Timens (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)
| |
Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women
B. Hamdi (Ariana, Tunisia), S. Louhaichy (Ariana, Tunisia), M. Mlika (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), K. Hamzaoui (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
| |
Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control
S. Smirnova (Krasnoyarsk, Russian Federation), N. Gorbacheva (Krasnoyarsk, Russian Federation), V. Belenyuk (Krasnoyarsk, Russian Federation), S. Zobova (Krasnoyarsk, Russian Federation), M. Smolnikova (Krasnoyarsk, Russian Federation)
| |
Neutrophilic asthma features increased airway classical monocytes
M. Fricker (New Lambton Heights (NSW), Australia), N. Niessen (New Lambton Heights (NSW), Australia), K. Baines (New Lambton Heights (NSW), Australia), J. Simpson (New Lambton Heights (NSW), Australia), H. Scott (New Lambton Heights (NSW), Australia), P. Gibson (New Lambton Heights (NSW), Australia)
| |
Sputum mast cells associate with clinical and inflammatory features of asthma
M. Fricker (New Lambton Heights (NSW), Australia), L. Qin (Xiangya Lambton Heights (NSW), China), N. Niessen (New Lambton Heights (NSW), Australia), K. Baines (New Lambton Heights (NSW), Australia), H. Scott (New Lambton Heights (NSW), Australia), J. Simpson (New Lambton Heights (NSW), Australia), P. Gibson (New Lambton Heights (NSW), Australia)
| |
Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom)
| |
Assessing permeability biomarkers of dual responders in allergic asthmatics
N. van der Burg (Lund, Sweden), H. Stenberg (Lund, Sweden), Z. Diamant (Groningen, Netherlands), L. Bjermer (Lund, Sweden), E. Tufvesson (Lund, Sweden)
| |
Chronic Cough is associated with higher levels of Systemic Immune Inflammation Index
J. Arinze (Rotterdam, Netherlands), L. Karimi (Rotterdam, Netherlands), E. De Roos (Rotterdam, Netherlands), J. Fest (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands), B. Stricker (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands)
| |
Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.
S. Graff (Liège, Belgium), S. Vanwynsberghe (Ghent, Belgium), G. Brusselle (Ghent, Belgium), S. Hanon (Brussels, Belgium), C. Sohy (Namur, Belgium), L. Dupont (Leuven, Belgium), R. Peche (Charleroi, Belgium), A. Michils (Brussels, Belgium), C. Pilette (Brussels, Belgium), G. Joos (Ghent, Belgium), R. Louis (Liège, Belgium), F. Schleich (Liège, Belgium)
| |
An improved assay for detection of sputum periostin in patients with asthma
A. James (Stockholm, Sweden), J. Ono (Sagamihara, Japan), K. Izuhara (Saga, Japan), S. Dahlén (Stockholm, Sweden), .. On Behalf Of Bioair Study Group (Stockholm, Sweden)
| |
Is CCL18 a potential biomarker of type-2 asthma?
H. Fouquet (Lille Cedex, France), J. Giovannelli (Lille Cedex, France), P. De Nadaï (Lille Cedex, France), J. Balsamelli (Lille Cedex, France), P. Berger (BordeauxCedex, France), A. Bourdin (Montpellier, France), P. Chanez (Marseille, France), S. Fry (Lille Cedex, France), T. Perez (Lille Cedex, France), A. Magnan (Nantes, France), M. Pretolani (Paris Cedex, France), C. Taillé (Paris, France), A. Tsicopoulos (Lille Cedex, France), C. Chenivesse (Lille Cedex, France)
| |
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
C. Bachert (Ghent, Belgium), J. Mullol (Barcelona, Spain), N. Daizadeh (Cambridge, United States of America), K. Wolfe (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), R. Johnson (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France), N. Amin (Tarrytown, United States of America), S. Harel (Tarrytown, United States of America), A. Jagerschmidt (Chilly-Mazarin, France)
| |